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At 150 K, the title compound, C9H11NO4S, crystallizes in the 
orthorhombic form as a zwitterion and has a low gauche 
conformation [ = 46.23 (16)] for an acyclic cysteine 
derivative. A difference in bond length is observed for the 
alkyl C—S bond [1.8299 (15) A˚ ] and the aryl C—S bond 
+[1.7760 (15) A˚ ]. The –NH3 group is involved in four hydrogen 
bonds, two of which are intermolecular and two intra­
molecular. The compound forms an inﬁnite three-dimensional 
network constructed from four intermolecular hydrogen 
bonds. Characterization data (13C NMR, IR and optical 
rotation) are reported to supplement the incomplete data 
disclosed previously in the literature. 
Comment 
(2R)-S-(2,5-Dihydroxyphenyl)cysteine, (I), is the adduct 
formed by nucleophilic attack of cysteine thiol on p-benzo­
quinone. It was investigated as a reducing agent (Hatanaka et 
al., 1972) and has been reported in the context of a study on 
inhibitors of betacyanin synthesis (Hayashi & Koshimizu, 
1979). It has also been the subject of a mass spectrometry 
study (d’Ischia et al., 1996). It is a very useful biochemical tool 
and has been used in the investigation of the metabolism of 
benzene, phenol and hydroquinone (Bratton et al., 1997; 
Lunte & Kissinger, 1983) and of the metabolism of acet­
aminophen/paracetamol (Pascoe et al., 1988; Axworthy et al., 
1988). It has been shown to be cytotoxic to melanoma cells 
(Yamada et al., 1988) and it is believed that the mode of action 
is tyrosinase inhibition. Indeed, the tyrosinase inhibitory 
activity of (I) has been disclosed in a recent patent concerning 
the use of the compound as a skin-brightening agent (Wempe 
& Clauson, 2008). Applications of (I) in hair dyeing (Wenke & 
Prota, 1995) and permanent waving (Kubo & Schultz, 1994) 
have also been patented. 
Concerning the synthesis of (I), an early reported proce­
dure (Kuhn & Beinert, 1944) was subsequently reinvestigated 
(Crescenzi et al., 1988) and it was found that, under certain 
conditions, a mixture of 1,4-benzothiazine oligomers may be 
formed in preference to the desired product. We undertook 
synthesis of (I) by addition of p-benzoquinone in ethanol to 
l-cysteine in H2O (Hayashi & Koshimizu, 1979). Spectro­
scopic characterization of (I) to date has been incomplete. 
Thus, we report here the high-ﬁeld 1H and 13C NMR spectra, 
IR spectrum and optical rotation of (I). 
The asymmetric unit of (I) (Fig. 1) contains one molecule of 
(2R)-S-(2,5-dihydroxyphenyl)cysteine, which forms hydrogen 
bonds with every heteroatom except sulfur. The protonated 
amino group on its own forms two intramolecular hydrogen 
bonds, viz. N1—H1B  O2 and N1—H1C  O3, and two 
intermolecular hydrogen bonds, viz. N1—H1A  O1iii and 
N1—H1B  O4iv (symmetry codes as in Table 2). In combi­
nation with the two hydrogen-bond-forming OH groups of the 
hydroquinone moiety, this gives rise to an inﬁnite three-
dimensional network of N—H  O and  O—H  O bonds. 
Details of these hydrogen bonds are given in Table 2 and the 
hydrogen-bond network is illustrated in Fig. 2. In the crys­
tallographic literature only two other cysteine derivatives with 
a cyclic substituent on the S atom have been reported, 5-S­
cysteinyluracil monohydrate (Williams et al., 1977) and 
S-benzyl-l-cysteine (Troup et al., 2001). Bond lengths in these 
cysteinyl units are very similar to the corresponding bond 
lengths found in (I). 
The structure we report here serves to explain the reported 
reactivity trends of (I) and aspects of the characterization data 
obtained for (I) by other techniques, as well as to suggest an 
application for (I) in peptide engineering. Firstly, phenolic 
alkylthioethers such as (I) have been reported (Costantini et 
al., 1994; d’Ischia et al., 1995) to show a marked proclivity for 
undergoing UV-induced desulfurization via regiospeciﬁc alkyl 
C—S bond cleavage and to fragment in a similar fashion under 
Figure 1 
The molecular structure and atom-labelling scheme of (I). Displacement 
ellipsoids are depicted at the 50% probability level and H atoms are 
shown as small spheres of arbitrary radii. 
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Figure 2 
The hydrogen-bond network (thin lines) of (I). 
conditions of mass spectrometric analysis (d’Ischia et al., 
1996). A rationale for the speciﬁc cleavage of the C3—S1 bond 
in this process may be derived from inspection of the crystal 
structure. Speciﬁcally, the observed C3—S1 bond length in (I) 
of 1.8299 (15) A˚ is appreciably longer than the C4—S1 bond 
length of 1.7760 (15) A˚ . Bond length and strength have 
previously been correlated for C—S bonds (Woodard et al., 
1976; Polenov et al., 2006; Seidel et al., 2007). Thus, it may be 
deduced that the C3—S1 bond in (I) is the weaker of the two 
C—S bonds, so rationalizing the observation that the C3—S1 
bond is particularly susceptible to regiospeciﬁc scission. 
Secondly, discrepancies between the 13C NMR spectra for 
(I) and l-cysteine may be rationalized on the basis of the 
present crystal structure. The C3 methylene resonance is 
observed at  = 34.5 p.p.m. for (I), but has been observed by us 
at  = 25.5 p.p.m. for l-cysteine (both in DMSO-d6; DMSO is  
dimethyl sulfoxide). This signiﬁcant downﬁeld shift (� = 
9.0 p.p.m.) upon introduction of the substituent on S implies 
that the electron-rich aryl ring exerts a deshielding effect. We 
propose this to be a consequence of the arene ring current and 
of conjugation of the S atom with the arene -system: electron 
donation into the ring lowers the electron density on the S 
atom, deshielding the nucleus of the adjacent atom C3. The 
difference in observed bond lengths for C4—S1 and C3—S1 
provides compelling evidence for higher bond order for the 
C4—S1 bond and hence for the deshielding effect detailed 
above (the inequivalence of the C4—S1 and C3—S1 bond 
lengths will persist in solution). 
Thirdly, as can be seen in Table 1, the cysteine N1—C2— 
C3—S1 moiety adopts a very low gauche torsion angle of 
46.23 (16) , due to the intramolecular N1—H1C  O3 
hydrogen bond. No lower N—C—C—S torsion angle has thus 
far been reported for an acyclic cysteine derivative. In this 
conformation, the small angle allows direct alignment of O3 
with the N1—H1C bond for optimal hydrogen bonding. A 
similarly low N—C—C—S torsion angle has previously only 
been described in four structures of cysteine derivatives: 
46.5 (2) and 47.8 (3) for cysteine mandelic acid diaster­
eomers (Fujii et al., 2005), 48.2 (3) for S-benzyl-l-cysteine 
(Troup et al., 2001), 48.8 for S-carboxymethyl-l-cysteine 
(Mighell et al., 1979) and 48.9 (3) in l-cysteine l-tartrate 
monohydrate (Shan & Huang, 1999). It is noteworthy that the 
N1—C2—C3—S1 torsion angle that we have observed is 
similar to the values of 45.6 (3) and 48.8 (3) reported 
(Ranganathan et al., 2002) in a dimeric structure of a closely 
analogous l-cysteinylaryl derivative in which the N—C—C—S 
motif is explicitly constrained by incorporation into a seven-
membered ring. This supports the conclusion that in the case 
of (I) it is the intramolecular hydrogen bond that is respon­
sible for the anomalously low N—C—C—S torsion angle. 
To conclude, it should be noted that this accurate structure 
constitutes an additional tool for rational peptide design. The 
OH functionality in the non-natural sulfur substituent of (I) 
results in a signiﬁcant change in the N—C—C—S torsion 
angle in the amino acid moiety. Use of this non-natural amino 
acid with such an unusual torsion angle will allow the rational 
design of new peptides of deﬁned secondary structure. 
Indeed, several oligopeptides containing (2R)-S-(2,5-dihydroxy­
phenyl)cysteine have been reported (Hansen et al., 2001; 
Ahlfors et al., 2003; Holmdahl et al., 2008), although none has 
been characterized by crystallography so far. We anticipate 
that the low torsion angle will orient the polarized aromatic 
ring such that it will exhibit – interactions with appropriate 
proximate aryl residues (Waters, 2004), which will confer 
deﬁned secondary structure on the peptide. 
Experimental 
The title compound was prepared as described previously (Hayashi & 
Koshimizu, 1979). The crude product was dissolved in reﬂuxing 
ethanol–water (100 ml; 1:1 v/v) and ﬁltered whilst hot. The ﬁltrate 
was allowed to cool to room temperature and was stored at 277 K for 
3 d to give (I) (yield 6.54 g, 77%) as a yellow crystalline solid of 
sufﬁcient quality for crystal structure analysis. []D 
25 +165 (c 1.0, 1 M 
HClaq); 
1H NMR (500 MHz, DMSO-d6, 298 K):  8.50 (5H, br s, –OH  
and –NH), 6.84 (1H, d, J = 2.5 Hz, Ar–H), 6.71 (1H, d, J = 8.5  Hz, Ar–  
H), 6.54 (1H, dd, J = 8.5 and 2.5 Hz, Ar-H), 3.35 (1H, dd, J = 13.5 and 
4.0 Hz, –S—CHH–), 3.31 (1H, dd, J = 8.5 and 4.5 Hz, –S—CH2—CH–), 
2.96 (1H, dd, J = 13.5 and 9.0 Hz, –S—CHH–); 13C NMR (75.4 MHz, 
DMSO-d6, 298 K):  169.6, 150.5, 149.4, 120.1, 118.0, 116.4, 115.4, 53.4, 
34.5; IR (ﬁlm, max, cm  
1): 3093, 3000, 2692, 2581, 1630, 1578, 1440, 
1388, 1339, 1251, 1206, 1132, 1051, 939, 904, 855, 820, 779, 659. 
Crystal data 
C9H11NO4S V = 982.92 (3) A˚ 
3 
Mr = 229.25 Z = 4  
Orthorhombic, P212121 Mo K radiation 
a = 5.1661 (1) A˚  = 0.32 mm1 
b = 10.3981 (2) A˚ T = 150 K 
c = 18.2979 (3) A˚ 0.40  0.38  0.38 mm 
Data collection 
Nonius KappaCCD area-detector 22623 measured reﬂections 
diffractometer 2875 independent reﬂections 
Absorption correction: multi-scan 2507 reﬂections with I > 2(I) 
(SORTAV; Blessing, 1995) Rint = 0.062 
Tmin = 0.882, Tmax = 0.887 
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Table 1 
Selected geometric parameters (A˚ , ). 
S1—C4 
S1—C3 
N1—C2 
O1—C1 
1.7760 (15) 
1.8299 (15) 
1.491 (2) 
1.2527 (19) 
O2—C1 
O3—C5 
O4—C8 
1.2517 (19) 
1.3779 (18) 
1.3718 (16) 
C4—S1—C3 
O2—C1—O1 
O2—C1—C2 
O1—C1—C2 
N1—C2—C3 
N1—C2—C1 
C2—C3—S1 
99.59 (7) 
127.29 (14) 
117.22 (13) 
115.47 (14) 
110.81 (12) 
109.13 (12) 
113.81 (10) 
C5—C4—S1 
C9—C4—S1 
O3—C5—C6 
O3—C5—C4 
O4—C8—C9 
O4—C8—C7 
122.25 (11) 
118.67 (11) 
121.67 (13) 
118.48 (13) 
121.93 (14) 
118.14 (14) 
O2—C1—C2—N1 
O1—C1—C2—N1 
9.67 (18) 
171.61 (13) 
N1—C2—C3—S1 
S1—C4—C5—O3 
46.23 (16) 
2.47 (19) 
Table 2 
Hydrogen-bond geometry (A˚ , ). 
D—H  A D—H H  A D  A D—H  A 
O3—H3  O2i 0.94 (3) 1.68 (3) 2.6214 (16) 177 (3) 
O4—H4  O1ii 0.82 (2) 1.82 (2) 2.6402 (18) 179 (2) 
N1—H1A  O1iii 0.88 (3) 2.24 (3) 2.8231 (17) 124 (2) 
N1—H1B  O4iv 0.96 (3) 2.11 (3) 2.8399 (18) 132 (2) 
N1—H1B  O2 0.96 (3) 2.12 (3) 2.6223 (19) 111 (2) 
N1—H1C  O3 0.95 (3) 1.88 (3) 2.822 (2) 175 (2) 
Symmetry codes: (i) x; y  12; z þ 32; (ii) x þ 12; y þ 32; z þ 1; (iii) x þ 1; y  21, z þ 3; (iv) x þ 1; y þ 1; z þ 12.2 2
Reﬁnement 
R[F 2 > 2(F 2)] = 0.034 �	max = 0.22 e A˚ 
3 
wR(F 2) = 0.077 �	min = 0.28 e A˚ 3 
S = 1.05 Absolute structure: Flack (1983), 
2875 reﬂections with 1188 Friedel pairs 
156 parameters Flack parameter: 0.06 (6) 
H atoms treated by a mixture of 
independent and constrained

reﬁnement

All H atoms attached to N and O atoms were located in a differ­
ence Fourier map and their positions and isotropic displacement 
parameters were reﬁned freely. All other H atoms were placed in 
calculated positions and reﬁned using a riding model, with C—H = 
0.95 (aromatic), 0.99 (methylene) or 1.00 A˚ (methine) and Uiso(H) = 
1.2Ueq(C). 
Data collection: COLLECT (Nonius, 2000); cell reﬁnement: 
SCALEPACK (Otwinowski & Minor, 1997); data reduction: 
DENZO and SCALEPACK (Otwinowski & Minor, 1997); 
program(s) used to solve structure: SIR97 (Altomare et al., 1999); 
program(s) used to reﬁne structure: SHELXL97 (Sheldrick, 2008); 
molecular graphics: ORTEP-3 for Windows (Farrugia, 1997); soft­
ware used to prepare material for publication: WinGX (Farrugia, 
1999) and DIAMOND (Brandenburg, 2005). 
The authors thank the University of Bath for funding. 
Supplementary data for this paper are available from the IUCr electronic 
archives (Reference: MX3028). Services for accessing these data are 
described at the back of the journal. 
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